Does ROSUVASTATIN Cause Dyslipidaemia? 206 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 206 reports of Dyslipidaemia have been filed in association with ROSUVASTATIN (Rosuvastatin Calcium). This represents 0.6% of all adverse event reports for ROSUVASTATIN.
206
Reports of Dyslipidaemia with ROSUVASTATIN
0.6%
of all ROSUVASTATIN reports
0
Deaths
38
Hospitalizations
How Dangerous Is Dyslipidaemia From ROSUVASTATIN?
Of the 206 reports, 38 (18.4%) required hospitalization, and 1 (0.5%) were considered life-threatening.
Is Dyslipidaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROSUVASTATIN. However, 206 reports have been filed with the FAERS database.
What Other Side Effects Does ROSUVASTATIN Cause?
Myalgia (3,958)
Dyspnoea (2,832)
Pain (2,758)
Drug ineffective (2,347)
Fatigue (2,208)
Rhabdomyolysis (2,173)
Arthralgia (1,879)
Asthma (1,843)
Muscle spasms (1,843)
Pain in extremity (1,686)
What Other Drugs Cause Dyslipidaemia?
OLANZAPINE (230)
ARIPIPRAZOLE (185)
METHOTREXATE (175)
QUETIAPINE (161)
ATORVASTATIN (155)
RISPERIDONE (154)
METFORMIN (151)
TACROLIMUS (149)
ZIPRASIDONE (149)
PREDNISONE (148)
Which ROSUVASTATIN Alternatives Have Lower Dyslipidaemia Risk?
ROSUVASTATIN vs ROSUVASTATIN\ROSUVASTATIN
ROSUVASTATIN vs ROTIGOTINE
ROSUVASTATIN vs ROXADUSTAT
ROSUVASTATIN vs ROXICODONE
ROSUVASTATIN vs ROXITHROMYCIN